Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Selumetinib in Patients With Kaposi's Sarcoma (SCART)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2014 by Sheffield Teaching Hospitals NHS Foundation Trust.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
University of Birmingham
AstraZeneca
Thermo Fisher Scientific
Cancer Research UK
University of Sheffield
Information provided by (Responsible Party):
Sheffield Teaching Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01752569
First received: August 17, 2012
Last updated: September 18, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)